Copyright
©The Author(s) 2020.
World J Hepatol. Apr 27, 2020; 12(4): 137-148
Published online Apr 27, 2020. doi: 10.4254/wjh.v12.i4.137
Published online Apr 27, 2020. doi: 10.4254/wjh.v12.i4.137
Table 1 Probes and conditions used in the polymerase chain reaction to genotype interleukin 6 single nucleotide polymorphism at position-174 (rs1800795)
IL-6 Gene-174 (rs1800795) | |
ACTTTTCCCCCTAGTTGTGTCTTGC[C/G]ATGCTAAAGGACGTCACATTGCACA | 60 ºC–1 min; 95 ºC–10 min; 50 cycles (95 ºC–15 s, 60 ºC–90 s) and 60 ºC–1 min |
Table 2 The interleukin genotype distribution in patients with chronic hepatitis C (n = 245) and healthy controls (n = 179)
Variables | CHC, n (%) | Control, n (%) | P value |
IL-6 genotypes | |||
-174 | 0.81 | ||
C/C | 18 (7.3) | 13 (7.3) | |
G/C | 85 (34.7) | 68 (38.0) | |
G/G | 142 (58.0) | 98 (54.7) | |
Total | 245 (100) | 179 (100) | |
HWE (P value) | 0.38 | 0.95 |
Table 3 Demographic, clinical comorbidity, nutritional status, liver fibrosis stage, virological, cytokine genotyping data of the chronically hepatitis C virus-infected patients with (n = 51) and without type 2 diabetes (n = 194)
Variables | Type 2 diabetes, n (%) | Non-type 2 diabetes, n (%) | P value |
Demographic | |||
Male | 27 (52.9) | 102 (52.6) | 1.0 |
Female | 24 (47.1) | 92 (47.4) | |
Age (yr)1 | 55.5 ± 9.6 | 50.9 ± 11.7 | 0.01 |
Clinical comorbidity | |||
Blood hypertension | 36 (70.6) | 62 (32.0) | < 0.001 |
Nutritional status | |||
Body mass index (Kg/m2)2 | 27.0 (24.1-29.7) | 25.6 (23.5-28.4) | 0.11 |
Stage of liver disease | |||
Chronic hepatitis C | 28 (54.9) | 123 (63.4) | 0.34 |
Liver cirrhosis | 23 (45.1) | 71 (36.6) | |
Virological parameters | |||
Viral load HCV-RNA [Log10 (IU/mL)]2 | 5.98 (5.66-6.24) | 5.84 (5.30-6.40) | 0.38 |
Genotype 1 | 40/45 (88.9) | 130/159 (81.7) | 0.37 |
IL-6 polymorphism | |||
IL-6-174G/G genotypes | 0.04 | ||
G/G | 37 (72.5) | 105 (54.1) | |
G/C | 13 (25.5) | 72 (37.1) | |
C/C | 1 (2.0) | 17 (8.8) | |
Total | 51 (100.0) | 194 (100.0) | |
HWE (P value) | 0.65 | 0.47 |
Table 4 Variables associated with diabetes mellitus in patients with chronic hepatitis C
Variables | Multivariate analysis | ||
OR | 95%CI | P value | |
Age | 1.01 | 0.98-1.05 | 0.43 |
Body mass index | 1.03 | 0.96-1.09 | 0.45 |
Hypertension | 5.56 | 2.79-11.09 | < 0.001 |
IL-6-174 G/C (GC and CC) | 0.42 | 0.22-0.78 | 0.006 |
- Citation: da Silva CB, Vieira DA, de Melo LF, Chagas ALS, Gomes AD, Faria Jr CLL, Teixeira R, de Magalhães Queiroz DM, Rocha GA, Soares MMS, Bezerra JMT, Silva LD. Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus. World J Hepatol 2020; 12(4): 137-148
- URL: https://www.wjgnet.com/1948-5182/full/v12/i4/137.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i4.137